Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1173311

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1173311

North America AI In Cancer Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user, By Component, By Cancer Type, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 76 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The North America AI In Cancer Diagnostics Market would witness market growth of 27.8% CAGR during the forecast period (2022-2028).

The complete and updated MRI-guided biopsies designed by the NCI scientists are now accessible in the clinic and hospitals which don't require the need of cancer-specific professionals due to this AI tool. The new AI-featured algorithms have overpassed the abilities of professional radiologists by allowing the forecast of patient reports utilizing MRI. However, advanced AI methods can be employed to discover the gene mutations from tumor pathology images rather than utilizing standard genomic sequencing.

For example, scientists at New York University backed by the NCI utilized the deep learning technique to discover pathology images of lung tumors received from the Cancer Genome Atlas. Deep learning techniques can also be utilized to distinguish and detect Adenocarcinoma and squamous cell carcinoma which are the most prevalent lung cancer subtypes along with the identification of the altered genes from the images.

In collaboration with the Department of Energy (DOE), the Cancer Moonshot is assisting two crucial efforts to utilize its supercomputing expertise and capacity for cancer research and development. Moreover, Artificial intelligence is utilized to analyze and explain characteristics of the targeted molecules such as nucleic or protein acids that are crucial for the evolution of cancer also AI helps to predict new medication for targeted molecules and assets evaluating the efficacy of the medication.

Cancer is one of the foremost causes of mortality in the United States. The early-stage diagnosis of cancer is still a complicated procedure in most healthcare facilities. Due to the growing government actions and growing recession along with the enhancement in the healthcare industry. There were 863,830 female cases and 888,905 male cases of new invasive cancer recorded in the United States in 2019. The incidence rate for all cancers combined was 439 per 100,000 people in the general population.

The US market dominated the North America AI In Cancer Diagnostics Market by Country in 2021; thereby, achieving a market value of $146.7 million by 2028. The Canada market is experiencing a CAGR of 30.7% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 29.6% during (2022 - 2028).

Based on End-user, the market is segmented into Hospital, Surgical Centers & Medical Institutes and Others. Based on Component, the market is segmented into Software Solutions, Hardware and Services. Based on Cancer Type, the market is segmented into Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer & Cervical Cancer, Prostate & Colorectal Cancer and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.

Scope of the Study

Market Segments covered in the Report:

By End-user

  • Hospital
  • Surgical Centers & Medical Institutes
  • Others

By Component

  • Software Solutions
  • Hardware
  • Services

By Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Brain Tumor
  • Skin Cancer & Cervical Cancer
  • Prostate & Colorectal Cancer
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • Microsoft Corporation
  • Flatiron Health
  • Paige AI, Inc.
  • PathAI, Inc.
  • Therapixel
  • Tempus, Inc.
  • SkinVision BV
  • Cancer Center Sp. z o.o.
  • Medial EarlySign
  • Kheiron Medical Technologies Limited

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America AI In Cancer Diagnostics Market, by End-user
    • 1.4.2 North America AI In Cancer Diagnostics Market, by Component
    • 1.4.3 North America AI In Cancer Diagnostics Market, by Cancer Type
    • 1.4.4 North America AI In Cancer Diagnostics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenarios
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players

Chapter 4. North America AI In Cancer Diagnostics Market by End-user

  • 4.1 North America Hospital Market by Country
  • 4.2 North America Surgical Centers & Medical Institutes Market by Country
  • 4.3 North America Others Market by Country

Chapter 5. North America AI In Cancer Diagnostics Market by Component

  • 5.1 North America Software Solutions Market by Country
  • 5.2 North America Hardware Market by Country
  • 5.3 North America Services Market by Country

Chapter 6. North America AI In Cancer Diagnostics Market by Cancer Type

  • 6.1 North America Breast Cancer Market by Country
  • 6.2 North America Lung Cancer Market by Country
  • 6.3 North America Brain Tumor Market by Country
  • 6.4 North America Skin Cancer & Cervical Cancer Market by Country
  • 6.5 North America Prostate & Colorectal Cancer Market by Country
  • 6.6 North America Others Market by Country

Chapter 7. North America AI In Cancer Diagnostics Market by Country

  • 7.1 US AI In Cancer Diagnostics Market
    • 7.1.1 US AI In Cancer Diagnostics Market by End-user
    • 7.1.2 US AI In Cancer Diagnostics Market by Component
    • 7.1.3 US AI In Cancer Diagnostics Market by Cancer Type
  • 7.2 Canada AI In Cancer Diagnostics Market
    • 7.2.1 Canada AI In Cancer Diagnostics Market by End-user
    • 7.2.2 Canada AI In Cancer Diagnostics Market by Component
    • 7.2.3 Canada AI In Cancer Diagnostics Market by Cancer Type
  • 7.3 Mexico AI In Cancer Diagnostics Market
    • 7.3.1 Mexico AI In Cancer Diagnostics Market by End-user
    • 7.3.2 Mexico AI In Cancer Diagnostics Market by Component
    • 7.3.3 Mexico AI In Cancer Diagnostics Market by Cancer Type
  • 7.4 Rest of North America AI In Cancer Diagnostics Market
    • 7.4.1 Rest of North America AI In Cancer Diagnostics Market by End-user
    • 7.4.2 Rest of North America AI In Cancer Diagnostics Market by Component
    • 7.4.3 Rest of North America AI In Cancer Diagnostics Market by Cancer Type

Chapter 8. Company Profiles

  • 8.1 Microsoft Corporation
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 SWOT Analysis
  • 8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Segmental and Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 Recent strategies and developments:
      • 8.2.5.1 Partnerships, Collaborations, and Agreements:
  • 8.3 Paige AI, Inc.
    • 8.3.1 Company Overview
    • 8.3.2 Recent strategies and developments:
      • 8.3.2.1 Partnerships, Collaborations, and Agreements:
      • 8.3.2.2 Product Launches and Product Expansions:
  • 8.4 PathAI, Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Recent strategies and developments:
      • 8.4.2.1 Partnerships, Collaborations, and Agreements:
      • 8.4.2.2 Acquisition and Mergers:
  • 8.5 Therapixel
    • 8.5.1 Company Overview
    • 8.5.2 Recent strategies and developments:
      • 8.5.2.1 Product Launches and Product Expansions:
  • 8.6 Tempus, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Recent strategies and developments:
      • 8.6.2.1 Partnerships, Collaborations, and Agreements:
  • 8.7 SkinVision BV
    • 8.7.1 Company Overview
  • 8.8 Cancer Center Sp. z o.o.
    • 8.8.1 Company Overview
  • 8.9 Medial EarlySign
    • 8.9.1 Company Overview
  • 8.10. Kheiron Medical Technologies Limited
    • 8.10.1 Company Overview
    • 8.10.2 Recent strategies and developments:
      • 8.10.2.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

  • TABLE 1 North America AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 2 North America AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 3 Partnerships, Collaborations and Agreements- AI In Cancer Diagnostics Market
  • TABLE 4 Product Launches And Product Expansions- AI In Cancer Diagnostics Market
  • TABLE 5 Acquisition and Mergers- AI In Cancer Diagnostics Market
  • TABLE 6 North America AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 7 North America AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 8 North America Hospital Market by Country, 2018 - 2021, USD Thousands
  • TABLE 9 North America Hospital Market by Country, 2022 - 2028, USD Thousands
  • TABLE 10 North America Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
  • TABLE 11 North America Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
  • TABLE 12 North America Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 13 North America Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 14 North America AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 15 North America AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 16 North America Software Solutions Market by Country, 2018 - 2021, USD Thousands
  • TABLE 17 North America Software Solutions Market by Country, 2022 - 2028, USD Thousands
  • TABLE 18 North America Hardware Market by Country, 2018 - 2021, USD Thousands
  • TABLE 19 North America Hardware Market by Country, 2022 - 2028, USD Thousands
  • TABLE 20 North America Services Market by Country, 2018 - 2021, USD Thousands
  • TABLE 21 North America Services Market by Country, 2022 - 2028, USD Thousands
  • TABLE 22 North America AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 23 North America AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 24 North America Breast Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 25 North America Breast Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 26 North America Lung Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 27 North America Lung Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 28 North America Brain Tumor Market by Country, 2018 - 2021, USD Thousands
  • TABLE 29 North America Brain Tumor Market by Country, 2022 - 2028, USD Thousands
  • TABLE 30 North America Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 31 North America Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 32 North America Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
  • TABLE 33 North America Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
  • TABLE 34 North America Others Market by Country, 2018 - 2021, USD Thousands
  • TABLE 35 North America Others Market by Country, 2022 - 2028, USD Thousands
  • TABLE 36 North America AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
  • TABLE 37 North America AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
  • TABLE 38 US AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 39 US AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 40 US AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 41 US AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 42 US AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 43 US AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 44 US AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 45 US AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 46 Canada AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 47 Canada AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 48 Canada AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 49 Canada AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 50 Canada AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 51 Canada AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 52 Canada AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 53 Canada AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 54 Mexico AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 55 Mexico AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 56 Mexico AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 57 Mexico AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 58 Mexico AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 59 Mexico AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 60 Mexico AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 61 Mexico AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 62 Rest of North America AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
  • TABLE 63 Rest of North America AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
  • TABLE 64 Rest of North America AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
  • TABLE 65 Rest of North America AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
  • TABLE 66 Rest of North America AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
  • TABLE 67 Rest of North America AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
  • TABLE 68 Rest of North America AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
  • TABLE 69 Rest of North America AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
  • TABLE 70 key information - Microsoft Corporation
  • TABLE 71 Key Information - Flatiron Health
  • TABLE 72 Key Information -Paige AI, Inc.
  • TABLE 73 Key Information - PathAI, Inc.
  • TABLE 74 Key Information -Therapixel
  • TABLE 75 Key Information - Tempus, Inc.
  • TABLE 76 Key Information - SkinVision BV
  • TABLE 77 Key Information - Cancer Center Sp. z o.o.
  • TABLE 78 Key Information - Medial EarlySign
  • TABLE 79 Key Information - Kheiron Medical Technologies Limited

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players
  • FIG 5 SWOT Analysis: Microsoft Corporation
  • FIG 6 Recent strategies and developments: Paige AI, Inc.
  • FIG 7 Recent strategies and developments: PathAI, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!